Ashley Christian
Psychiatric/Mental Health · Poplar Bluff, MONPI 1073070702
Payments from drug & device makers
Across 169 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$478
- Alkermes, Inc.$411
- Johnson & Johnson$406
- Neurocrine Biosciences, Inc.$377
- Teva Pharmaceuticals USA, Inc.$296
- Lundbeck LLC$259
- plus $903 from 8 others
What the payments were for
- Food & beverage$3,122100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $478 |
| Alkermes, Inc. | 26 | $411 |
| Johnson & Johnson | 22 | $406 |
| Neurocrine Biosciences, Inc. | 20 | $377 |
| Teva Pharmaceuticals USA, Inc. | 16 | $296 |
| Lundbeck LLC | 12 | $259 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $204 |
| E.r. Squibb & Sons, L.L.C. | 10 | $194 |
| Axsome Therapeutics, Inc. | 8 | $184 |
| Indivior Inc. | 8 | $141 |
| AbbVie | 5 | $79 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
How this compares
$3,129 in reported general payments places this provider in the 80th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 28 | $3,440 |
| Divalproex Sodium | 14 | $1,250 |
| Fluoxetine Hcl | 31 | $835 |
| Buspirone Hcl | 35 | $813 |
| Doxepin Hcl | 11 | $766 |
| Olanzapine | 34 | $591 |
| Hydroxyzine Hcl | 55 | $554 |
| Prazosin Hcl | 43 | $538 |
| Duloxetine Hcl | 27 | $483 |
| Risperidone | 38 | $465 |
| Carbamazepine | 12 | $419 |
| Oxcarbazepine | 12 | $358 |
| Trazodone Hcl | 44 | $329 |
| Mirtazapine | 36 | $251 |
| Quetiapine Fumarate | 23 | $160 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Poplar Bluff
- Kristerpher BrimberryPoplar Bluff$74K
- Camellia VermillionPoplar Bluff$6K
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.